The AJCC Cancer Staging Manual (7 th edition, 2010) has introduced a novel TNM staging classification for pancreatic neuroendocrine tumors which is derived from the staging system for exocrine pancreatic adenocarcinomas. This classification has not yet been validated.
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA Background: The AJCC Cancer Staging Manual (7 th edition, 2010) has introduced a novel TNM staging classification for pancreatic neuroendocrine tumors which is derived from the staging system for exocrine pancreatic adenocarcinomas. This classification has not yet been validated.
Methods:
Patients with pancreatic neuroendocrine tumors treated at the H. Lee Moffitt Cancer Center between 1999 and 2010 were assigned a stage (I-IV) based on the new AJCC classification. Overall survival from time of initial diagnosis was measured and statistical significance calculated using the log-rank test. The prognostic relevance of the AJCC staging classification was compared to the relevance of a staging classification proposed recently by the European Neuroendocrine Tumor Society (ENETS).
Results:
425 patients with histologically proven pancreatic neuroendocrine tumors were identified.
Both the novel AJCC classification and the ENETS classification were highly prognostic for survival (p<0.00001; table 1).
Conclusions:
The novel AJCC 7 th Edition TNM classification for pancreatic neuroendocrine tumors is highly prognostic for overall survival and should be adopted in clinical practice. 
